Zantac, generic name Ranitidine, is an over-the-counter medication that decreases stomach acid production. Recently the FDA recalled Zantac stating the drug contains unsafe levels of the cancer-causing substance N-Nitrosodimethylamine (NDMA).
Sanders Phillips Grossman is filing lawsuits against Sanofi and Boerhringer Ingelheim for failure to warn about these dangerous and potentially deadly side effects. If you have been diagnosed with cancer after using Zantac, including bladder cancer, stomach cancer, liver fibrosis and scarring, and tumors in the liver, kidneys, and lungs, please contact us for a free case evaluation.
RECEIVE A FREE ZANTAC LAWSUIT EVALUATION
Anyone who used Zantac and was diagnosed with cancer may be eligible for a lawsuit against Sanofi and Boerhringer Ingelheim. Zantac lawsuits can recover compensation for medical bills, lost wages, physical and mental suffering, and other losses that result from their cancer.
Sanders Phillips Grossman is a nationally-recognized law firm with a strong track record of holding big companies accountable for marketing dangerous and defective products. The firm and its affiliates have been protecting victims’ rights for over 50 years and have recovered more than $40 billion for our clients.
To discuss a Zantac lawsuit with an attorney, free of charge, please contact Sanders Phillips Grossman for a free consultation. You pay no out-of-pocket legal fees, and no fees at all unless we win your case.
Lawsuits are being filed alleging that drug manufacturers intentionally withheld information from consumers and the medical community about the risks of cancer with these heartburn medications. If you or a loved one have been diagnosed with cancer after using Zantac, including bladder cancer, stomach cancer, liver fibrosis, and scarring, and tumors in the liver, kidneys, and lungs you may be eligible for compensation from the drug manufacturer.